what glp 1 is the safest GLP-1 Safety Check Understanding GLP-1 Drugs: Cost, Safety,
Description
At 3 months, semaglutide typically produces 6 to 8% weight loss while tirzepatide produces 7 to 10%
Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC
The findings were consistent after accounting for age, race, ethnicity, body mass index (BMI), breast density, and diabetes
Where semaglutide activates one receptor (GLP-1) and tirzepatide activates two (GLP-1 and GIP), retatrutide adds glucagon receptor agonism
